Large-scale testing (Phase 3)Study completedNCT02890784What this trial is testingDasatinib Holiday for Improved TolerabilityWho this might be right forMyeloid Leukemia, Chronic University of Jena 291
Not applicableEnded earlyNCT00918658What this trial is testingStudy of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT01254188What this trial is testingSafety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia PatientsWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 421
Not applicableNo Longer AvailableNCT00302016What this trial is testingExpanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00357708What this trial is testingVorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other DiseasesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+10 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01220648What this trial is testingDetermining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 4
Early research (Phase 1)Study completedNCT01456676What this trial is testingNilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior TherapyWho this might be right forPhiladelphia Chromosome Positive Chronic Myelogenous Leukemia Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Ended earlyNCT01050946What this trial is testingHematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord UnitWho this might be right forLeukemia, Lymphocytic, AcuteLeukemia, Lymphocytic, ChronicLeukemia, Myelocytic, Acute+3 more Medical College of Wisconsin 1
Testing effectiveness (Phase 2)WithdrawnNCT02923986What this trial is testingClinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDSWho this might be right forChronic Myelogenous Leukemia, Ph1-PositiveAcute Myeloid LeukemiaMyelodysplastic Syndrome Bio-Path Holdings, Inc.
Not applicableStudy completedNCT00619879What this trial is testingMyeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric MalignanciesWho this might be right forLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more Ann & Robert H Lurie Children's Hospital of Chicago 81
Early research (Phase 1)Study completedNCT00686218What this trial is testingPanobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia City of Hope Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00002674What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00354120What this trial is testingThymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic TransplantWho this might be right forAcute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more Gruppo Italiano Trapianto di Midollo Osseo 121
Early research (Phase 1)Study completedNCT00217646What this trial is testingSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia+21 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00881946What this trial is testingRepeat Dose Safety Study for Compound to Treat Hematologic CancerWho this might be right forHematologic Malignancies Accenture 73
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00281879What this trial is testingDonor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 200
Testing effectiveness (Phase 2)Study completedNCT01030718What this trial is testingRollover Study of BMS-354825 in Patients With CML and Ph+ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Bristol-Myers Squibb 54
Testing effectiveness (Phase 2)Ended earlyNCT02795520What this trial is testingPharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaWho this might be right forAMLAdvanced MDSALL+2 more OncoTherapy Science, Inc. 32
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167